Voyager Therapeutics Inc (NASDAQ:VYGR)’s Stock Is Sell After More Market Selling

June 14, 2018 - By Ash Ash

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Logo

The stock of Voyager Therapeutics Inc (NASDAQ:VYGR) registered an increase of 0.78% in short interest. VYGR’s total short interest was 2.32 million shares in June as published by FINRA. Its up 0.78% from 2.30 million shares, reported previously. With 334,100 shares average volume, it will take short sellers 7 days to cover their VYGR’s short positions. The short interest to Voyager Therapeutics Inc’s float is 14.02%.

The stock increased 0.23% or $0.05 during the last trading session, reaching $21.64. About 270,346 shares traded. Voyager Therapeutics, Inc. (NASDAQ:VYGR) has risen 112.00% since June 14, 2017 and is uptrending. It has outperformed by 99.43% the S&P500.

Voyager Therapeutics, Inc., a clinical-stage gene therapy company, focuses on the development of treatments for patients suffering from severe diseases of the central nervous system. The company has market cap of $699.43 million. The companyÂ’s lead clinical candidate is the VY-AADC01, which is in Phase Ib clinical trial for the treatment of advanced Parkinson's disease. It currently has negative earnings. The Company’s preclinical programs comprise VY-SOD101 for a monogenic form of amyotrophic lateral sclerosis; VY-HTT01 for HuntingtonÂ’s disease; VY-FXN01 for Friedreich's ataxia; VY-TAU01, AlzheimerÂ’s disease; and VY-NAV01 for severe chronic pain.

More notable recent Voyager Therapeutics, Inc. (NASDAQ:VYGR) news were published by: Globenewswire.com which released: “Voyager Therapeutics Announces Management Change” on May 29, 2018, also Seekingalpha.com with their article: “Premarket analyst action – healthcare” published on June 04, 2018, Nasdaq.com published: “Voyager Therapeutics Announces Additional Data at the American Society of Gene and Cell Therapy 2018 Annual …” on May 18, 2018. More interesting news about Voyager Therapeutics, Inc. (NASDAQ:VYGR) were released by: Streetinsider.com and their article: “UPDATE: HC Wainwright Starts Voyager Therapeutics (VYGR) at Buy” published on June 04, 2018 as well as Investorplace.com‘s news article titled: “7 Strong Buy Stocks Analysts Are Upgrading Now, Including Facebook, Inc.” with publication date: June 13, 2018.

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.